Brief: Oncternal Therapeutics Reports Qtrly Loss Per Share $0.23

Oncternal Therapeutics

09/08/2022 22:24

Aug 9 (Reuters) - Oncternal Therapeutics Inc  ONCT.O :
    * ONCTERNAL THERAPEUTICS PROVIDES BUSINESS UPDATE AND
ANNOUNCES
SECOND QUARTER 2022 FINANCIAL RESULTS
    * ONCTERNAL THERAPEUTICS - EXTENDED CASH RUNWAY GUIDANCE TO
FUND
OPERATIONS INTO H1 2024 WITH $78.9 MILLION IN CASH AND NO DEBT
AS OF JUNE 30, 2022
    * QTRLY LOSS PER SHARE $0.23
    * Q2 EARNINGS PER SHARE VIEW $-0.23, REVENUE VIEW $459000.00
--
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX2RpSR 
Further company coverage:  ONCT.O 

 ((Reuters.Briefs@thomsonreuters.com;))